catalyst grant : environments, genes and chronic disease
eligibility criteria for all cihr research funding programs apply. the business office of the institution of an eligible nominated principal applicant generally administers cihr funds. refer to the individual eligibility requirements regarding the eligibility requirements for individuals and institutions.
eligibility to apply
for your application to be eligible:
- the nominated principal applicant must be an independent researcher.
- the application must include at least one other principal applicant, who is an independent researcher with expertise in a different discipline than the nominated principal applicant (team leader).
- the nominated principal applicant must be appointed at an eligible institution (see institutional eligibility requirements for eligibility process and associated timelines.
note: applicants may only apply to the funding opportunity once as a nominated principal applicant. they can, however, participate on other applications in other roles such as "other principal applicant", "co-applicant" or "collaborator".
randomized controlled trials
randomized controlled trials (rct) will not be considered under this funding opportunity.
the objective of this catalyst grant program is to fund catalyst grants that will generate preliminary data and facilitate research collaborations. these catalyst grants will:
- provide researchers with financial support to synthesize knowledge and develop state-of-the-art approaches to address the contributions of environment-gene interactions to chronic disease with the goal of defining opportunities for targeted research initiatives.
- develop inter-disciplinary collaborations between researchers of different backgrounds (including, but not limited to, basic scientists, geneticists, environmental scientists, epidemiologists, biostatisticians, and social scientists) in order to integrate the tools, research designs, and methods currently used in studies addressing the roles of environment and genes on chronic disease.